.
MergerLinks Header Logo

New Deal


Announced

Completed

Advent and Great Hill completed the investment in RxBenefits at a $1.1bn valuation.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

pharmacy plans

United States

Friendly

Domestic

Private Equity

pharmacy benefits

Majority

Private

Single Bidder

Knowledge Process Outsourcing

Acquisition

Completed

Synopsis

Edit

Private equity firms Advent International and Great Hill Partners completed the investment in RxBenefits, a provider of pharmacy plans, expert advice, superior service, and guaranteed rates, at a $1.1bn valuation. "RxBenefits is the industry’s only fully independent, client-aligned, multi-PBM platform delivering tangible pharmacy savings, optimized clinical outcomes and a superior customer experience. Advent brings a robust track record in the healthcare services and tech sectors, and their investment is a testament to the opportunities ahead. We look forward to growing in partnership with Advent and Great Hill as we continue to build out our specialty and clinical programs to deliver additional cost savings to our clients," Bryan Statham, RxBenefits CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US